Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
loteprednol (lotemax) (1 trial)
Eye Infections (Phase 3)
Inflammation (Phase 3)
Trials (1 total)
Trial APIs (1 total)